Cleo Diagnostics Ltd Financial Flexibility Index

Latest as of December 2025: -1.47x

Cleo Diagnostics Ltd financial flexibility index. Cleo Diagnostics Ltd (COV) has a Financial Flexibility Index of -1.47x as of December 2025. Free cash flow of AU$-1.67 Million (operating CF AU$-1.67 Million minus capex AU$1.96K) represents -1% of total liabilities (AU$1.14 Million).

Financial Flexibility Index

-1.47x
Free Cash Flow / Total Liabilities

Free Cash Flow

AU$-1.67 Million
Operating CF − Capex

Total Liabilities

AU$1.14 Million
AUD

Capital Expenditures

AU$1.96K
AUD

Financial Flexibility Index of Cleo Diagnostics Ltd (2023–2025)

Financial flexibility index of Cleo Diagnostics Ltd from 2023 to 2025. Historical Financial Flexibility Index trend for Cleo Diagnostics Ltd across 3 annual periods. Explore Cleo Diagnostics Ltd (COV) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cleo Diagnostics Ltd Financial Flexibility Index by Year (2023–2025)

Cleo Diagnostics Ltd financial flexibility index by year from 2023 to 2025. Year-by-year free cash flow to debt coverage for Cleo Diagnostics Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Cleo Diagnostics Ltd.

Year Flexibility Index Free Cash Flow (AUD) Operating CF Total Liabilities YoY Change
2025 -2.62x AU$-2.89 Million AU$-2.90 Million AU$1.10 Million ▲ +37.1%
2024 -4.17x AU$-2.03 Million AU$-2.03 Million AU$486.22K ▼ -2346.6%
2023 -0.17x AU$-344.23K AU$-684.47K AU$2.02 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities